Going mobile

Article

You’re dating yourself if the song from The Who is going through your head after reading the headline of this editorial. Hmmm…maybe I am dating myself with the reference!

You’re dating yourself if the song from The Who is going through your head after reading the headline of this editorial. Hmmm…maybe I am dating myself with the reference!

I know I talked with you in this space not long ago about our new app. But I feel the need to talk about it again. It really is quite cool. If you haven’t taken a look yet, download it for free now! 

Our new app brings you our content on the go. Want to catch up on some professional reading while sitting on the train/on the plane/waiting for your kid’s soccer game to finish? The app is the best way to do that. Everything that’s in the print journal-and then some (coming soon)-awaits you. Soon, we’ll be bringing you app-exclusive content.

I especially like how crisp and clean our content looks. Articles are easy to read and digest. And don’t get me started on our pop-out charts and images. Slideshows make our clinical images really shine. It’s really cool that you can listen to our “OD Q&A” subject in his or her own words-the MP3 lives there in the app with the story.

I know I’m fan girling over our app. But guess what? You are, too! Each month, more of you are downloading it. Each month, our “cover-to-cover” readers are increasing. Those numbers tell us that you’re liking what you’re seeing, and you’re reading more of it. Data to warm the heart of an editor.

I’d love to hear your thoughts on where you’re reading Optometry Times via app. Drop me a line: gbailey@advanstar.com.ODT

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.